AlphaCentric Life Sciences and Healthcare Fund Class A (LYFAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
12.11
+0.10 (0.83%)
Jun 6, 2025, 4:00 PM EDT
LYFAX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 9.18% |
2 | UNH | UnitedHealth Group Incorporated | 8.40% |
3 | JNJ | Johnson & Johnson | 5.02% |
4 | ABBV | AbbVie Inc. | 4.98% |
5 | AZN | AstraZeneca PLC | 4.23% |
6 | MRK | Merck & Co., Inc. | 3.72% |
7 | BSX | Boston Scientific Corporation | 3.47% |
8 | NVSN.MX | NOVARTIS AG-ADR | 3.21% |
9 | TMO | Thermo Fisher Scientific Inc. | 3.02% |
10 | VRTX | Vertex Pharmaceuticals Incorporated | 2.70% |
11 | GMED | Globus Medical, Inc. | 2.44% |
12 | ABT | Abbott Laboratories | 2.28% |
13 | ISRG | Intuitive Surgical, Inc. | 2.25% |
14 | CVS | CVS Health Corporation | 2.23% |
15 | BMY | Bristol-Myers Squibb Company | 2.19% |
16 | CI | The Cigna Group | 2.16% |
17 | GILD | Gilead Sciences, Inc. | 2.15% |
18 | FXFXX | First American Treasury Obligations Fund | 1.91% |
19 | PFE | Pfizer Inc. | 1.79% |
20 | BDX | Becton, Dickinson and Company | 1.62% |
21 | DHR | Danaher Corporation | 1.55% |
22 | ELV | Elevance Health, Inc. | 1.54% |
23 | ATRC | AtriCure, Inc. | 1.53% |
24 | NBIX | Neurocrine Biosciences, Inc. | 1.34% |
25 | EHC | Encompass Health Corporation | 1.28% |
26 | EW | Edwards Lifesciences Corporation | 1.25% |
27 | ZBH | Zimmer Biomet Holdings, Inc. | 1.20% |
28 | CHE | Chemed Corporation | 1.17% |
29 | SYK | Stryker Corporation | 1.13% |
30 | EXAS | Exact Sciences Corporation | 0.94% |
31 | TRUMY | Terumo Corporation | 0.93% |
32 | HOLX | Hologic, Inc. | 0.87% |
33 | DXCM | DexCom, Inc. | 0.79% |
34 | VRNA | Verona Pharma plc | 0.77% |
35 | ZTS | Zoetis Inc. | 0.75% |
36 | USPH | U.S. Physical Therapy, Inc. | 0.69% |
37 | IRTC | iRhythm Technologies, Inc. | 0.69% |
38 | WST | West Pharmaceutical Services, Inc. | 0.68% |
39 | DSNKY | Daiichi Sankyo Company, Limited | 0.68% |
40 | NEOG | Neogen Corporation | 0.67% |
41 | ADPT | Adaptive Biotechnologies Corporation | 0.67% |
42 | AORT | Artivion, Inc. | 0.65% |
43 | KRYS | Krystal Biotech, Inc. | 0.64% |
44 | ICLR | ICON Public Limited Company | 0.62% |
45 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.62% |
46 | REGN | Regeneron Pharmaceuticals, Inc. | 0.61% |
47 | INSM | Insmed Incorporated | 0.54% |
48 | COR | Cencora, Inc. | 0.53% |
49 | KIDS | OrthoPediatrics Corp. | 0.51% |
50 | ALDX | Aldeyra Therapeutics, Inc. | 0.49% |
51 | SGRY | Surgery Partners, Inc. | 0.48% |
52 | AVDL | Avadel Pharmaceuticals plc | 0.48% |
53 | APGE | Apogee Therapeutics, Inc. | 0.47% |
54 | PTGX | Protagonist Therapeutics, Inc. | 0.46% |
55 | IONS | Ionis Pharmaceuticals, Inc. | 0.43% |
56 | EWTX | Edgewise Therapeutics, Inc. | 0.41% |
57 | BNTX | BioNTech SE | 0.35% |
58 | AGIO | Agios Pharmaceuticals, Inc. | 0.34% |
59 | CRL | Charles River Laboratories International, Inc. | 0.29% |
60 | TNDM | Tandem Diabetes Care, Inc. | 0.28% |
61 | ADUS | Addus HomeCare Corporation | 0.26% |
62 | SDZNY | Sandoz Group AG | 0.23% |
63 | ORKA | Oruka Therapeutics, Inc. | 0.11% |
64 | n/a | Fidelity Institutional Cash Portfolios - FID-MM GOVT-I | 0.00% |
As of Mar 31, 2025